Truist raised the firm’s price target on DaVita (DVA) to $158 from $128 and keeps a Hold rating on the shares. The firm is adjusting its model to reflect the company’s Q4 earnings beat and above-consensus 2026 guide, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DVA:
- DaVita price target raised to $144 from $133 at TD Cowen
- DaVita price target raised to $190 from $186 at UBS
- Balanced View: DaVita’s near-term EBIT upside offset by structural growth hurdles
- DaVita Earnings Call Signals Cautious Optimism
- DaVita Stock (DVA) Soars 20% as Financial Results Beat Wall Street Estimates